Comparison of immunogenicity and reactogenicity of two trivalent influenza virus vaccines in South Korean children
Phase of Trial: Phase III
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors GC Pharma; Green Cross
- 02 Jan 2018 According to a GC Pharma media release, Green Cross Corporation rebrands itself to GC Pharma.
- 08 Dec 2011 New trial record
- 01 Nov 2011 Results published in the Journal of Korean Medical Science.